Horrell Capital Management, Inc. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Horrell Capital Management, Inc. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2020$8,000
+300.0%
1,0000.0%0.00%
+200.0%
Q3 2020$2,000
-75.0%
1,0000.0%0.00%
-75.0%
Q2 2020$8,000
+60.0%
1,0000.0%0.00%
+33.3%
Q1 2020$5,0000.0%1,0000.0%0.00%
+50.0%
Q4 2019$5,0000.0%1,0000.0%0.00%0.0%
Q3 2019$5,000
-28.6%
1,0000.0%0.00%
-33.3%
Q2 2019$7,0000.0%1,0000.0%0.00%
-25.0%
Q1 2019$7,0001,0000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$3,107,0001.71%
ETF MANAGERS GROUP, LLC 14,138,998$8,534,0000.17%
Ikarian Capital, LLC 948,526$584,0000.09%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 318,668$196,0000.03%
Platform Technology Partners 45,000$28,0000.01%
XTX Topco Ltd 34,476$21,0000.01%
PINNACLE ASSOCIATES LTD 947,083$583,0000.01%
Penserra Capital Management LLC 537,236$330,0000.01%
Mirae Asset Global Investments Co., Ltd. 4,070,006$2,506,0000.01%
Tekla Capital Management LLC 154,310$95,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders